HEADER DNA BINDING PROTEIN 03-MAY-18 6GGC TITLE P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER TITLE 2 PK9320 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELLULAR TUMOR ANTIGEN P53; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANTIGEN NY-CO-13,PHOSPHOPROTEIN P53,TUMOR SUPPRESSOR P53; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TP53, P53; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS P53, TRANSCRIPTION FACTOR, TUMOR SUPRESSOR, CANCER THERAPY, ONCOGENIC KEYWDS 2 MUTANT, PROTEIN MISFOLDING, SMALL-MOLECULE STABILIZER, MOLECULAR KEYWDS 3 CHAPERONE, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.C.JOERGER REVDAT 3 17-JAN-24 6GGC 1 REMARK REVDAT 2 30-OCT-19 6GGC 1 JRNL REVDAT 1 22-MAY-19 6GGC 0 JRNL AUTH M.R.BAUER,R.N.JONES,R.K.TAREQUE,B.SPRINGETT,F.A.DINGLER, JRNL AUTH 2 L.VERDUCI,K.J.PATEL,A.R.FERSHT,A.C.JOERGER,J.SPENCER JRNL TITL A STRUCTURE-GUIDED MOLECULAR CHAPERONE APPROACH FOR JRNL TITL 2 RESTORING THE TRANSCRIPTIONAL ACTIVITY OF THE P53 CANCER JRNL TITL 3 MUTANT Y220C. JRNL REF FUTURE MED CHEM V. 11 2491 2019 JRNL REFN ISSN 1756-8927 JRNL PMID 31633398 JRNL DOI 10.4155/FMC-2019-0181 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.C.JOERGER,H.C.ANG,A.R.FERSHT REMARK 1 TITL STRUCTURAL BASIS FOR UNDERSTANDING ONCOGENIC P53 MUTATIONS REMARK 1 TITL 2 AND DESIGNING RESCUE DRUGS. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 103 15056 2006 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 17015838 REMARK 1 DOI 10.1073/PNAS.0607286103 REMARK 2 REMARK 2 RESOLUTION. 1.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 137101 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.151 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 6934 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5320 - 3.8477 0.98 4607 209 0.1539 0.1547 REMARK 3 2 3.8477 - 3.0550 0.98 4442 228 0.1531 0.1604 REMARK 3 3 3.0550 - 2.6691 0.99 4416 232 0.1620 0.1898 REMARK 3 4 2.6691 - 2.4252 0.99 4387 229 0.1603 0.1668 REMARK 3 5 2.4252 - 2.2515 1.00 4423 217 0.1528 0.1597 REMARK 3 6 2.2515 - 2.1187 1.00 4376 235 0.1475 0.1718 REMARK 3 7 2.1187 - 2.0127 1.00 4364 240 0.1440 0.1645 REMARK 3 8 2.0127 - 1.9251 1.00 4349 216 0.1413 0.1471 REMARK 3 9 1.9251 - 1.8510 1.00 4372 238 0.1411 0.1796 REMARK 3 10 1.8510 - 1.7871 1.00 4308 268 0.1368 0.1491 REMARK 3 11 1.7871 - 1.7312 1.00 4392 229 0.1293 0.1490 REMARK 3 12 1.7312 - 1.6818 0.99 4307 248 0.1284 0.1471 REMARK 3 13 1.6818 - 1.6375 1.00 4320 236 0.1251 0.1531 REMARK 3 14 1.6375 - 1.5975 1.00 4363 242 0.1281 0.1628 REMARK 3 15 1.5975 - 1.5612 1.00 4316 228 0.1294 0.1484 REMARK 3 16 1.5612 - 1.5280 1.00 4335 223 0.1293 0.1657 REMARK 3 17 1.5280 - 1.4974 1.00 4362 215 0.1301 0.1438 REMARK 3 18 1.4974 - 1.4692 1.00 4352 214 0.1316 0.1561 REMARK 3 19 1.4692 - 1.4429 1.00 4306 241 0.1354 0.1697 REMARK 3 20 1.4429 - 1.4185 0.99 4310 221 0.1447 0.1792 REMARK 3 21 1.4185 - 1.3956 1.00 4288 240 0.1540 0.1948 REMARK 3 22 1.3956 - 1.3741 0.99 4326 231 0.1594 0.1624 REMARK 3 23 1.3741 - 1.3539 0.99 4262 263 0.1618 0.1823 REMARK 3 24 1.3539 - 1.3349 0.99 4323 226 0.1644 0.1807 REMARK 3 25 1.3349 - 1.3168 1.00 4317 226 0.1665 0.1833 REMARK 3 26 1.3168 - 1.2997 0.99 4304 224 0.1776 0.2095 REMARK 3 27 1.2997 - 1.2835 0.99 4239 250 0.1898 0.2281 REMARK 3 28 1.2835 - 1.2680 0.99 4320 218 0.1943 0.2098 REMARK 3 29 1.2680 - 1.2533 0.98 4244 244 0.1975 0.2189 REMARK 3 30 1.2533 - 1.2392 0.95 4137 203 0.2079 0.2111 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.100 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.700 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3261 REMARK 3 ANGLE : 0.808 4454 REMARK 3 CHIRALITY : 0.083 485 REMARK 3 PLANARITY : 0.006 586 REMARK 3 DIHEDRAL : 15.168 1223 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GGC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200009780. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 137227 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.240 REMARK 200 RESOLUTION RANGE LOW (A) : 29.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.03800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2J1X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 6 MG/ML PROTEIN IN REMARK 280 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR REMARK 280 BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, REMARK 280 5 MM DTT. SOAKING BUFFER: SATURATED SOLUTION OF COMPOUND IN 100 REMARK 280 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) REMARK 280 POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL., REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.44700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.50800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.58600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.50800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.44700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.58600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 94 REMARK 465 SER A 95 REMARK 465 GLY A 293 REMARK 465 GLU A 294 REMARK 465 PRO A 295 REMARK 465 HIS A 296 REMARK 465 HIS A 297 REMARK 465 GLU A 298 REMARK 465 LEU A 299 REMARK 465 PRO A 300 REMARK 465 PRO A 301 REMARK 465 GLY A 302 REMARK 465 SER A 303 REMARK 465 THR A 304 REMARK 465 LYS A 305 REMARK 465 ARG A 306 REMARK 465 ALA A 307 REMARK 465 LEU A 308 REMARK 465 PRO A 309 REMARK 465 ASN A 310 REMARK 465 ASN A 311 REMARK 465 THR A 312 REMARK 465 LYS B 292 REMARK 465 GLY B 293 REMARK 465 GLU B 294 REMARK 465 PRO B 295 REMARK 465 HIS B 296 REMARK 465 HIS B 297 REMARK 465 GLU B 298 REMARK 465 LEU B 299 REMARK 465 PRO B 300 REMARK 465 PRO B 301 REMARK 465 GLY B 302 REMARK 465 SER B 303 REMARK 465 THR B 304 REMARK 465 LYS B 305 REMARK 465 ARG B 306 REMARK 465 ALA B 307 REMARK 465 LEU B 308 REMARK 465 PRO B 309 REMARK 465 ASN B 310 REMARK 465 ASN B 311 REMARK 465 THR B 312 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 120 CG CD CE NZ REMARK 470 ARG A 209 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 280 CD NE CZ NH1 NH2 REMARK 470 ARG A 290 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 291 CG CD CE NZ REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 LYS B 101 CD CE NZ REMARK 470 LYS B 120 CG CD CE NZ REMARK 470 LYS B 139 CE NZ REMARK 470 ARG B 209 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 280 CD NE CZ NH1 NH2 REMARK 470 ARG B 290 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 291 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 184 32.91 -97.87 REMARK 500 LEU A 188 -46.93 -135.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 176 SG REMARK 620 2 HIS A 179 ND1 104.5 REMARK 620 3 CYS A 238 SG 109.6 107.3 REMARK 620 4 CYS A 242 SG 112.1 106.2 116.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 176 SG REMARK 620 2 HIS B 179 ND1 105.1 REMARK 620 3 CYS B 238 SG 110.8 106.0 REMARK 620 4 CYS B 242 SG 111.4 107.2 115.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EXN A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EXN B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 403 DBREF 6GGC A 94 312 UNP P04637 P53_HUMAN 94 312 DBREF 6GGC B 94 312 UNP P04637 P53_HUMAN 94 312 SEQADV 6GGC LEU A 133 UNP P04637 MET 133 ENGINEERED MUTATION SEQADV 6GGC ALA A 203 UNP P04637 VAL 203 ENGINEERED MUTATION SEQADV 6GGC CYS A 220 UNP P04637 TYR 220 ENGINEERED MUTATION SEQADV 6GGC TYR A 239 UNP P04637 ASN 239 ENGINEERED MUTATION SEQADV 6GGC ASP A 268 UNP P04637 ASN 268 ENGINEERED MUTATION SEQADV 6GGC LEU B 133 UNP P04637 MET 133 ENGINEERED MUTATION SEQADV 6GGC ALA B 203 UNP P04637 VAL 203 ENGINEERED MUTATION SEQADV 6GGC CYS B 220 UNP P04637 TYR 220 ENGINEERED MUTATION SEQADV 6GGC TYR B 239 UNP P04637 ASN 239 ENGINEERED MUTATION SEQADV 6GGC ASP B 268 UNP P04637 ASN 268 ENGINEERED MUTATION SEQRES 1 A 219 SER SER SER VAL PRO SER GLN LYS THR TYR GLN GLY SER SEQRES 2 A 219 TYR GLY PHE ARG LEU GLY PHE LEU HIS SER GLY THR ALA SEQRES 3 A 219 LYS SER VAL THR CYS THR TYR SER PRO ALA LEU ASN LYS SEQRES 4 A 219 LEU PHE CYS GLN LEU ALA LYS THR CYS PRO VAL GLN LEU SEQRES 5 A 219 TRP VAL ASP SER THR PRO PRO PRO GLY THR ARG VAL ARG SEQRES 6 A 219 ALA MET ALA ILE TYR LYS GLN SER GLN HIS MET THR GLU SEQRES 7 A 219 VAL VAL ARG ARG CYS PRO HIS HIS GLU ARG CYS SER ASP SEQRES 8 A 219 SER ASP GLY LEU ALA PRO PRO GLN HIS LEU ILE ARG VAL SEQRES 9 A 219 GLU GLY ASN LEU ARG ALA GLU TYR LEU ASP ASP ARG ASN SEQRES 10 A 219 THR PHE ARG HIS SER VAL VAL VAL PRO CYS GLU PRO PRO SEQRES 11 A 219 GLU VAL GLY SER ASP CYS THR THR ILE HIS TYR ASN TYR SEQRES 12 A 219 MET CYS TYR SER SER CYS MET GLY GLY MET ASN ARG ARG SEQRES 13 A 219 PRO ILE LEU THR ILE ILE THR LEU GLU ASP SER SER GLY SEQRES 14 A 219 ASN LEU LEU GLY ARG ASP SER PHE GLU VAL ARG VAL CYS SEQRES 15 A 219 ALA CYS PRO GLY ARG ASP ARG ARG THR GLU GLU GLU ASN SEQRES 16 A 219 LEU ARG LYS LYS GLY GLU PRO HIS HIS GLU LEU PRO PRO SEQRES 17 A 219 GLY SER THR LYS ARG ALA LEU PRO ASN ASN THR SEQRES 1 B 219 SER SER SER VAL PRO SER GLN LYS THR TYR GLN GLY SER SEQRES 2 B 219 TYR GLY PHE ARG LEU GLY PHE LEU HIS SER GLY THR ALA SEQRES 3 B 219 LYS SER VAL THR CYS THR TYR SER PRO ALA LEU ASN LYS SEQRES 4 B 219 LEU PHE CYS GLN LEU ALA LYS THR CYS PRO VAL GLN LEU SEQRES 5 B 219 TRP VAL ASP SER THR PRO PRO PRO GLY THR ARG VAL ARG SEQRES 6 B 219 ALA MET ALA ILE TYR LYS GLN SER GLN HIS MET THR GLU SEQRES 7 B 219 VAL VAL ARG ARG CYS PRO HIS HIS GLU ARG CYS SER ASP SEQRES 8 B 219 SER ASP GLY LEU ALA PRO PRO GLN HIS LEU ILE ARG VAL SEQRES 9 B 219 GLU GLY ASN LEU ARG ALA GLU TYR LEU ASP ASP ARG ASN SEQRES 10 B 219 THR PHE ARG HIS SER VAL VAL VAL PRO CYS GLU PRO PRO SEQRES 11 B 219 GLU VAL GLY SER ASP CYS THR THR ILE HIS TYR ASN TYR SEQRES 12 B 219 MET CYS TYR SER SER CYS MET GLY GLY MET ASN ARG ARG SEQRES 13 B 219 PRO ILE LEU THR ILE ILE THR LEU GLU ASP SER SER GLY SEQRES 14 B 219 ASN LEU LEU GLY ARG ASP SER PHE GLU VAL ARG VAL CYS SEQRES 15 B 219 ALA CYS PRO GLY ARG ASP ARG ARG THR GLU GLU GLU ASN SEQRES 16 B 219 LEU ARG LYS LYS GLY GLU PRO HIS HIS GLU LEU PRO PRO SEQRES 17 B 219 GLY SER THR LYS ARG ALA LEU PRO ASN ASN THR HET ZN A 401 1 HET EXN A 402 23 HET EDO A 403 4 HET EDO A 404 4 HET ZN B 401 1 HET EXN B 402 23 HET GOL B 403 6 HETNAM ZN ZINC ION HETNAM EXN [9-ETHYL-7-(FURAN-2-YL)CARBAZOL-3-YL]METHYL-METHYL- HETNAM 2 EXN AZANIUM HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 EXN 2(C20 H21 N2 O 1+) FORMUL 5 EDO 2(C2 H6 O2) FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *444(H2 O) HELIX 1 AA1 HIS A 178 CYS A 182 5 5 HELIX 2 AA2 CYS A 277 LYS A 292 1 16 HELIX 3 AA3 HIS B 178 CYS B 182 5 5 HELIX 4 AA4 CYS B 277 LYS B 291 1 15 SHEET 1 AA1 4 ARG A 110 GLY A 112 0 SHEET 2 AA1 4 CYS A 141 TRP A 146 -1 O GLN A 144 N GLY A 112 SHEET 3 AA1 4 THR A 230 TYR A 236 -1 O THR A 230 N LEU A 145 SHEET 4 AA1 4 ILE A 195 VAL A 197 -1 N ARG A 196 O ASN A 235 SHEET 1 AA2 7 CYS A 124 SER A 127 0 SHEET 2 AA2 7 LYS A 132 CYS A 135 -1 O LYS A 132 N SER A 127 SHEET 3 AA2 7 LEU A 264 VAL A 274 1 O GLU A 271 N LEU A 133 SHEET 4 AA2 7 ILE A 251 GLU A 258 -1 N LEU A 257 O LEU A 265 SHEET 5 AA2 7 ARG A 156 TYR A 163 -1 N MET A 160 O ILE A 254 SHEET 6 AA2 7 HIS A 214 PRO A 219 -1 O VAL A 218 N VAL A 157 SHEET 7 AA2 7 GLU A 204 ASP A 207 -1 N GLU A 204 O VAL A 217 SHEET 1 AA3 4 ARG B 110 GLY B 112 0 SHEET 2 AA3 4 CYS B 141 TRP B 146 -1 O GLN B 144 N GLY B 112 SHEET 3 AA3 4 THR B 230 TYR B 236 -1 O THR B 230 N LEU B 145 SHEET 4 AA3 4 ILE B 195 VAL B 197 -1 N ARG B 196 O ASN B 235 SHEET 1 AA4 7 CYS B 124 SER B 127 0 SHEET 2 AA4 7 LYS B 132 CYS B 135 -1 O LYS B 132 N SER B 127 SHEET 3 AA4 7 LEU B 264 VAL B 274 1 O GLU B 271 N LEU B 133 SHEET 4 AA4 7 ILE B 251 GLU B 258 -1 N LEU B 257 O LEU B 265 SHEET 5 AA4 7 ARG B 156 TYR B 163 -1 N MET B 160 O ILE B 254 SHEET 6 AA4 7 HIS B 214 PRO B 219 -1 O VAL B 218 N VAL B 157 SHEET 7 AA4 7 GLU B 204 ASP B 207 -1 N GLU B 204 O VAL B 217 LINK SG CYS A 176 ZN ZN A 401 1555 1555 2.36 LINK ND1 HIS A 179 ZN ZN A 401 1555 1555 2.02 LINK SG CYS A 238 ZN ZN A 401 1555 1555 2.33 LINK SG CYS A 242 ZN ZN A 401 1555 1555 2.31 LINK SG CYS B 176 ZN ZN B 401 1555 1555 2.34 LINK ND1 HIS B 179 ZN ZN B 401 1555 1555 2.01 LINK SG CYS B 238 ZN ZN B 401 1555 1555 2.33 LINK SG CYS B 242 ZN ZN B 401 1555 1555 2.30 SITE 1 AC1 4 CYS A 176 HIS A 179 CYS A 238 CYS A 242 SITE 1 AC2 12 LEU A 145 VAL A 147 THR A 150 PRO A 151 SITE 2 AC2 12 CYS A 220 GLU A 221 PRO A 222 PRO A 223 SITE 3 AC2 12 ASP A 228 THR A 230 HOH A 615 HOH A 634 SITE 1 AC3 3 SER A 241 CYS A 275 ALA A 276 SITE 1 AC4 3 ASN A 131 LEU A 252 SER A 269 SITE 1 AC5 4 CYS B 176 HIS B 179 CYS B 238 CYS B 242 SITE 1 AC6 10 LEU B 145 VAL B 147 THR B 150 PRO B 151 SITE 2 AC6 10 CYS B 220 GLU B 221 PRO B 222 PRO B 223 SITE 3 AC6 10 ASP B 228 THR B 230 SITE 1 AC7 6 ARG B 174 GLN B 192 ASP B 207 PHE B 212 SITE 2 AC7 6 HIS B 214 HOH B 568 CRYST1 64.894 71.172 105.016 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015410 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014050 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009522 0.00000